PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma - PubMed (original) (raw)

PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma

C L Rosenberg et al. Proc Natl Acad Sci U S A. 1991.

Abstract

Rearrangement of the BCL1 (B-cell lymphoma 1) region on chromosome 11q13 appears to be highly characteristic of centrocytic lymphoma and also is found infrequently in other B-cell neoplasms. Rearrangement is thought to deregulate a nearby protooncogene, but transcribed sequences in the immediate vicinity of BCL1 breakpoints had not been identified. PRAD1, previously designated D11S287E, was identified on 11q13 as a chromosomal breakpoint region rearranged with the parathyroid hormone gene in a subset of parathyroid adenomas; this highly conserved putative oncogene, which encodes a novel cyclin, has been linked to BCL1 and implicated also in subsets of breast and squamous cell neoplasms with 11q13 amplification. We report pulsed-field gel electrophoresis data showing BCL1 and PRAD1 to be no more than 130 kilobases apart. PRAD1 mRNA is abundantly expressed in seven of seven centrocytic lymphomas (Kiel classification), in contrast to 13 closely related but noncentrocytic lymphomas. Three of the seven centrocytic lymphomas had detectable BCL1 DNA rearrangement. Also, two unusual cases of CLL with BCL1 rearrangement overexpressed PRAD1, in contrast to five CLL controls. Thus, PRAD1 is an excellent candidate "BCL1 oncogene." Its overexpression may be a key consequence of rearrangement of the BCL1 vicinity in B-cell neoplasms and a unifying pathogenetic feature in centrocytic lymphoma.

PubMed Disclaimer

Similar articles

• Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma.
  Williams ME, Swerdlow SH, Rosenberg CL, Arnold A. Williams ME, et al. Cancer Res. 1992 Oct 1;52(19 Suppl):5541s-5544s. Cancer Res. 1992. PMID: 1394169
• Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.
  Williams ME, Swerdlow SH, Rosenberg CL, Arnold A. Williams ME, et al. Leukemia. 1993 Feb;7(2):241-5. Leukemia. 1993. PMID: 8426477
• Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors.
  Rosenberg CL, Motokura T, Kronenberg HM, Arnold A. Rosenberg CL, et al. Oncogene. 1993 Feb;8(2):519-21. Oncogene. 1993. PMID: 8426754
• Implication of cyclin D1 in malignant lymphoma.
  Callanan M, Leroux D, Magaud JP, Rimokh R. Callanan M, et al. Crit Rev Oncog. 1996;7(3-4):191-203. doi: 10.1615/critrevoncog.v7.i3-4.30. Crit Rev Oncog. 1996. PMID: 9258602 Review.
• PRAD1/Cyclin D1 gene overexpression in mantle cell lymphoma.
  Oka K, Ohno T, Yamaguchi M, Mahmud N, Miwa H, Kita K, Shiku H, Shirakawa S. Oka K, et al. Leuk Lymphoma. 1996 Mar;21(1-2):37-42. doi: 10.3109/10428199609067577. Leuk Lymphoma. 1996. PMID: 8907267 Review.

Cited by

• Primary structure of the herpesvirus saimiri genome.
  Albrecht JC, Nicholas J, Biller D, Cameron KR, Biesinger B, Newman C, Wittmann S, Craxton MA, Coleman H, Fleckenstein B, et al. Albrecht JC, et al. J Virol. 1992 Aug;66(8):5047-58. doi: 10.1128/JVI.66.8.5047-5058.1992. J Virol. 1992. PMID: 1321287 Free PMC article.
• Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas.
  de Jong JS, van Diest PJ, Michalides RJ, Baak JP. de Jong JS, et al. Mol Pathol. 1999 Apr;52(2):78-83. doi: 10.1136/mp.52.2.78. Mol Pathol. 1999. PMID: 10474686 Free PMC article.
• Mantle cell lymphoma is characterized by inactivation of the ATM gene.
  Schaffner C, Idler I, Stilgenbauer S, Döhner H, Lichter P. Schaffner C, et al. Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2773-8. doi: 10.1073/pnas.050400997. Proc Natl Acad Sci U S A. 2000. PMID: 10706620 Free PMC article.
• Mutation-associated fusion cancer genes in solid tumors.
  Kaye FJ. Kaye FJ. Mol Cancer Ther. 2009 Jun;8(6):1399-408. doi: 10.1158/1535-7163.MCT-09-0135. Epub 2009 Jun 9. Mol Cancer Ther. 2009. PMID: 19509239 Free PMC article. Review.
• Targeting cyclin D1 as a therapeutic approach for papillary thyroid carcinoma.
  Cai W, Shu LZ, Liu DJ, Zhou L, Wang MM, Deng H. Cai W, et al. Front Oncol. 2023 Jun 22;13:1145082. doi: 10.3389/fonc.2023.1145082. eCollection 2023. Front Oncol. 2023. PMID: 37427143 Free PMC article. Review.

References

1. 1. Cancer Genet Cytogenet. 1984 Sep;13(1):17-28 - PubMed
2. 1. Science. 1984 Jun 29;224(4656):1403-6 - PubMed
3. 1. Blood. 1991 Jul 15;78(2):259-63 - PubMed
4. 1. Nature. 1991 Apr 11;350(6318):512-5 - PubMed
5. 1. Blood. 1990 Nov 15;76(10):2086-90 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc

• Research Materials

  • NCI CPTC Antibody Characterization Program